Recent
changes in drug labels: The following drugs had modifications to the
contraindications, warnings or precautions section of their labels: Adcetris
(brentuximab vedotin) for Injection; Arava (leflunomide) Tablets; AVELOX
(moxifloxacin hydrochloride) Tablets and IV; Bosulif (bosutinib) Tablets;
Cardizem (diltiazem hydrochloride) Tablets; Cubicin (daptomycin for injection)
Intravenous; Cymbalta (duloxetine) Delayed-release Capsules; Foscavir
(foscarnet sodium) Injection; Lopid (gemfibrozil) Tablets; Mycobutin
(rifabutin) Capsules; Mytelase (ambenonium chloride) Tablets; Sensipar
(cinacalcet hydrochloride) Tablets; Sovaldi (sofosbuvir) Tablet; Sylatron
(peginterferon alfa-2b); Taxotere (docetaxel) Injection Concentrate; Unasyn
(ampicillin sodium/sulbactam sodium) Injection; Votrient (pazopanib
hydrocholoride) Tablets and Zelboraf (vemurafenib) Tablet. Click
here for more information from the FDA.
Robert
Pear, for the New York Times, reported on a study which revealed that half
of the physicians listed as serving Medicaid patients were unavailable either
because they were not actually taking Medicaid patients or because the
information about their medical practice was outdated.
Robert
Preidt, for Health Day, discussed a study in the Annals of Epidemiology
that indicated that despite lower smoking rates, cigarettes are still
responsible for 3 out of 10 cancer deaths in the United States.
Marie
Ellis, with Medical News Today, reported on an article in JAMA Pediatrics
which found that children diagnosed with autism spectrum disorder were twice as
likely to be born with mothers with preeclampsia during pregnancy.
